Phase 2 Study of Monotherapy with Pembrolizumab for Advanced Adrenocortical Carcinoma
Introduction Adrenocortical carcinoma (ACC) is a rare cancer with suboptimal response to chemotherapy. The role of immunotherapy in ACC management is evolving. Methods An investigator-initiated, open-label, phase 2 clinical trial was performed to ascertain the activity and safety of monotherapy with...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Innovative Healthcare Institute
2025-10-01
|
| coleção: | Journal of Immunotherapy and Precision Oncology |
| Assuntos: | |
| Acesso em linha: | https://jipo.org/doi/pdf/10.36401/JIPO-25-6 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|